Navigating the Challenges of IgAN Management: Clinical Implications of Emerging B-Cell Therapies

Keeping Current ›

30:32 | Dec 24th, 2025

Alarming in immunoglobulin A nephropathy (IgAN): over 40% present late. Explore latest advancements in management of the most common cause of primary glomerulonephritis worldwide. Credit available for...Show More